PAR-2 agonists induce contraction of murine small intestine through neurokinin receptors

A Zhao, T Shea-Donohue - American Journal of Physiology …, 2003 - journals.physiology.org
A Zhao, T Shea-Donohue
American Journal of Physiology-Gastrointestinal and Liver …, 2003journals.physiology.org
Protease-activated receptor-2 (PAR-2) is a G protein-coupled receptor and is expressed
throughout the gut. It is well known that PAR-2 participates in the regulation of
gastrointestinal motility; however, the results are inconsistent. The present study investigated
the effect and mechanism of PAR-2 activation on murine small intestinal smooth muscle
function in vitro. Both trypsin and PAR-2-activating peptide SLIGRL induced a small
relaxation followed by a concentration-dependent contraction. The sensitivity to trypsin was …
Protease-activated receptor-2 (PAR-2) is a G protein-coupled receptor and is expressed throughout the gut. It is well known that PAR-2 participates in the regulation of gastrointestinal motility; however, the results are inconsistent. The present study investigated the effect and mechanism of PAR-2 activation on murine small intestinal smooth muscle function in vitro. Both trypsin and PAR-2-activating peptide SLIGRL induced a small relaxation followed by a concentration-dependent contraction. The sensitivity to trypsin was greater than that to SLIGRL (EC50 = 0.03 vs. 40 μM), but maximal responses were similar (12.3 ± 1.6 vs. 13.7 ± 1.3 N/cm2). Trypsin-evoked contraction (1 μM) exhibited a rapid desensitization, whereas the desensitization of response to SLIGRL was less even at high concentration (50 μM). Atropine had no effect on PAR-2 agonist-induced contractions. In contrast, TTX and capsaicin significantly attenuated those contractions, implicating a neurogenic mechanism that may involve capsaicin-sensitive sensory nerves. Furthermore, contractions induced by trypsin and SLIGRL were reduced by neurokinin receptor NK1 antagonist SR-140333 or NK2 antagonist SR-48968 alone or were further reduced by combined application of SR-140333 and SR-48968, indicating the involvement of neurokinin receptors. In addition, desensitizing neurokinin receptors with substance P and/or neurokinin A decreased the PAR-2 agonist-evoked contraction. We concluded that PAR-2 agonists induced a contraction of murine intestinal smooth muscle that was mediated by nerves. The excitatory effect is also dependent on sensory neural pathways and requires both NK1 and NK2 receptors.
American Physiological Society